Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

DA Davidson lowered the firm’s price target on Vertex (VERX) to $50 from $55 and keeps a Buy rating on the shares as part of a broader research ...

Vertex (VERX) announced the expansion of its Chief Strategy Office with the addition of Christopher Hall and Kathya Capote Peimbert. Their ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $475.49, marking a -1.41% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 3.46%.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Google has announced it is adding its text-to-music model Lyria to Vertex AI. Vertex AI is now the only generative AI ...

The government will freeze $2 billion in funds because the university refused to comply with its demands. Harvard leaders believed saying no was worth the risk. 7 min read Trump Threatens Harvard ...

For these applications, graph is a natural and powerful tool for modeling and capturing dependency relationships between objects. Unlike conventional data, where each instance is represented in a ...

For the automated version of GraphCL, please refer to https://github.com/Shen-Lab/GraphCL_Automated. For the extention of GraphCL to hypergraphs, please refer to ...